Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Detailed history and physical examination are crucial for diagnosing hair loss.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Finasteride helps hair growth but may cause sexual side effects and depression.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

The document says that there are treatments for hair and nail diseases.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

The document concludes that scalp conditions have various causes and can present in many different ways.

The document lists various dermatology topics, treatments, and diagnostic methods.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Hair loss in women can cause beauty and mental health problems, and there are various treatments available.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Black and Hispanic women are more likely to have alopecia areata than white women.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.